Amneal Pharmaceuticals Inc (AMRX)
8.245
-0.16
(-1.85%)
USD |
NASDAQ |
Nov 05, 16:00
8.25
0.00 (0.00%)
After-Hours: 19:07
Amneal Pharmaceuticals Enterprise Value: 5.223B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 5.223B |
| November 01, 2024 | 5.251B |
| October 31, 2024 | 5.245B |
| October 30, 2024 | 5.276B |
| October 29, 2024 | 5.269B |
| October 28, 2024 | 5.266B |
| October 25, 2024 | 5.223B |
| October 24, 2024 | 5.195B |
| October 23, 2024 | 5.198B |
| October 22, 2024 | 5.254B |
| October 21, 2024 | 5.245B |
| October 18, 2024 | 5.279B |
| October 17, 2024 | 5.241B |
| October 16, 2024 | 5.316B |
| October 15, 2024 | 5.350B |
| October 14, 2024 | 5.303B |
| October 11, 2024 | 5.276B |
| October 10, 2024 | 5.241B |
| October 09, 2024 | 5.310B |
| October 08, 2024 | 5.303B |
| October 07, 2024 | 5.241B |
| October 04, 2024 | 5.300B |
| October 03, 2024 | 5.269B |
| October 02, 2024 | 5.282B |
| October 01, 2024 | 5.316B |
| Date | Value |
|---|---|
| September 30, 2024 | 5.198B |
| September 27, 2024 | 5.158B |
| September 26, 2024 | 5.207B |
| September 25, 2024 | 5.204B |
| September 24, 2024 | 5.235B |
| September 23, 2024 | 5.260B |
| September 20, 2024 | 5.316B |
| September 19, 2024 | 5.350B |
| September 18, 2024 | 5.319B |
| September 17, 2024 | 5.356B |
| September 16, 2024 | 5.341B |
| September 13, 2024 | 5.291B |
| September 12, 2024 | 5.245B |
| September 11, 2024 | 5.211B |
| September 10, 2024 | 5.217B |
| September 09, 2024 | 5.241B |
| September 06, 2024 | 5.220B |
| September 05, 2024 | 5.238B |
| September 04, 2024 | 5.251B |
| September 03, 2024 | 5.251B |
| August 30, 2024 | 5.303B |
| August 29, 2024 | 5.306B |
| August 28, 2024 | 5.288B |
| August 27, 2024 | 5.248B |
| August 26, 2024 | 5.245B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.659B
Minimum
Apr 12 2023
5.356B
Maximum
Sep 17 2024
3.434B
Average
3.230B
Median
Apr 20 2021
Enterprise Value Benchmarks
| Eli Lilly and Co | 792.96B |
| Nutriband Inc | 57.13M |
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 5.994M |
| Revenue (Quarterly) | 701.78M |
| Total Expenses (Quarterly) | 618.84M |
| EPS Diluted (Quarterly) | 0.02 |
| Gross Profit Margin (Quarterly) | 35.62% |
| Profit Margin (Quarterly) | 0.85% |
| Earnings Yield | -7.52% |
| Operating Earnings Yield | 13.07% |
| Normalized Earnings Yield | -3.488 |